Delamanid or pretomanid? A Solomonic judgement!

Mudde, Saskia E; Upton, Anna M; Lenaerts, Anne; Bax, Hannelore I; De Steenwinkel, Jurriaan E M

Mudde, Saskia E; Upton, Anna M; Lenaerts, Anne; Bax, Hannelore I; De Steenwinkel, Jurriaan E M.

Afiliação

Mudde SE; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.
Upton AM; Evotec, Princeton, New Jersey, USA.
Lenaerts A; Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA.
Bax HI; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.
De Steenwinkel JEM; Department of Internal Medicine, Section of Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.

J Antimicrob Chemother ; 77(4): 880-902, 2022 03 31.

Article em En | MEDLINE | ID: mdl-35089314

Assuntos

Mycobacterium tuberculosis; Nitroimidazóis; Tuberculose Resistente a Múltiplos Medicamentos; Antituberculosos/farmacologia; Antituberculosos/uso terapêutico; Diarilquinolinas/uso terapêutico; Humanos; Nitroimidazóis/farmacologia; Nitroimidazóis/uso terapêutico; Oxazóis/farmacologia; Oxazóis/uso terapêutico; Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis / Nitroimidazóis Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google